ADBE Stock Ownership Activity

ADOBE INC 13F holders

8 value investing gurus have made changes to the ADOBE INC (ADBE) position according to the gurus' latest SEC quarterly report(s). ADBE has been bought (as a new position) by 1, completely sold out by 3 guru(s), the number of ADBE shares has been decreased by 4 super investor(s).

Which gurus or hedge funds are buying ADBE now?

According to the latest SEC filing(s) ADOBE INC (ADBE) has been bought by Robert Karr - Joho Capital (new buy).

To see more about who is investing in ADOBE INC (ADBE), please go to the ADBE ownership page.

2017 Q4 (6 results)
James Crichton
buy
+300,000
+1.97%
1.97%
John Armitage
+119.56%
+1,596,653
+2.45%
4.50%
Stephen Mandel
+47.27%
+1,858,632
+1.70%
5.30%
Leon Cooperman
+42.76%
+62,000
+0.41%
1.36%
David M. Polen
+1.17%
+73,489
+0.10%
8.29%
Eric H. Schoenstein
-0.63%
-400
-0.00%
0.14%
Current price: $504.60 187.95% AVG reported price*: $175.24
2017 Q3 (5 results)
Leon Cooperman
buy
+145,000
+0.84%
0.84%
John Armitage
+33.84%
+337,678
+0.45%
1.78%
David M. Polen
+3.73%
+226,286
+0.27%
7.55%
Eric H. Schoenstein
-1.11%
-721
-0.00%
0.13%
James Crichton
-100.00%
-400,000
-2.42%
0.00%
Current price: $504.60 238.25% AVG reported price*: $149.18
2017 Q2 (6 results)
David M. Polen
+31.52%
+1,452,892
+1.80%
7.50%
Eric H. Schoenstein
-3.22%
-2,155
-0.00%
0.13%
Stephen Mandel
-18.33%
-882,700
-0.63%
2.83%
James Crichton
-33.33%
-200,000
-1.16%
0.00%
John Armitage
-38.07%
-613,464
-0.87%
1.41%
Ole Andreas Halvorsen
-100.00%
-150,000
-0.13%
0.00%
Current price: $504.60 256.76% AVG reported price*: $141.44
2017 Q1 (6 results)
Ole Andreas Halvorsen
buy
+150,000
+0.09%
0.00%
John Armitage
buy
+1,611,207
+2.27%
2.27%
James Crichton
+50.00%
+200,000
+0.99%
2.98%
David M. Polen
+7.25%
+311,512
+0.38%
5.58%
Eric H. Schoenstein
-2.62%
-1,800
-0.00%
0.12%
Stephen Mandel
-4.24%
-213,003
-0.15%
3.30%
Current price: $504.60 287.76% AVG reported price*: $130.13
2016 Q4 (4 results)
James Crichton
buy
+400,000
+1.61%
1.61%
Stephen Mandel
+8.87%
+409,622
+0.22%
2.71%
David M. Polen
+8.43%
+334,110
+0.38%
4.87%
Eric H. Schoenstein
-1.22%
-850
-0.00%
0.10%
Current price: $504.60 390.14% AVG reported price*: $102.95
2016 Q3 (3 results)
David M. Polen
+3.25%
+124,739
+0.16%
5.13%
Eric H. Schoenstein
-2.32%
-1,650
-0.00%
0.11%
Stephen Mandel
-7.61%
-380,461
-0.18%
2.24%
Current price: $504.60 364.89% AVG reported price*: $108.54
2016 Q2 (5 results)
David M. Polen
+11.67%
+401,171
+0.49%
4.67%
Stephen Mandel
-1.47%
-74,670
-0.03%
2.21%
Eric H. Schoenstein
-7.99%
-6,180
-0.01%
0.11%
Rich Handler, Brian Friedman
-100.00%
-8,300
-0.09%
0.00%
Jeffrey Ubben
-100.00%
-6,000
-0.01%
0.00%
Current price: $504.60 426.78% AVG reported price*: $95.79
2016 Q1 (5 results)
Rich Handler, Brian Friedman
buy
+8,300
+0.11%
0.00%
Stephen Mandel
+26.44%
+1,060,923
+0.51%
2.42%
David M. Polen
+12.40%
+379,406
+0.49%
4.43%
Eric H. Schoenstein
-2.52%
-2,000
-0.00%
0.12%
Jeffrey Ubben
-99.96%
-14,004,739
-13.12%
0.00%
Current price: $504.60 437.85% AVG reported price*: $93.82
2015 Q4 (2 results)
David M. Polen
+11.47%
+314,700
+0.46%
4.44%
Stephen Mandel
-35.38%
-2,197,034
-0.92%
1.68%
Current price: $504.60 437.15% AVG reported price*: $93.94
2015 Q3 (4 results)
David M. Polen
+102.67%
+1,390,049
+2.09%
4.13%
Eric H. Schoenstein
-5.71%
-4,800
-0.01%
0.11%
Jeffrey Ubben
-10.78%
-1,693,000
-0.81%
6.70%
Stephen Mandel
-32.98%
-3,055,220
-1.12%
2.28%
Current price: $504.60 513.73% AVG reported price*: $82.22
2015 Q2 (4 results)
David M. Polen
-1.18%
-16,230
-0.03%
2.12%
Jeffrey Ubben
-1.89%
-303,014
-0.13%
6.70%
Eric H. Schoenstein
-2.44%
-2,100
-0.00%
0.11%
Stephen Mandel
-23.09%
-2,780,954
-1.00%
3.33%
Current price: $504.60 522.89% AVG reported price*: $81.01
50 of 267

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.